First it was Pfizer. Now Novartis has frozen drug prices in the US
July 18, 2018 at 08:07 AM EDT
Switzerland's Novartis is holding off on hiking drug prices in the United States, days after President Donald Trump called on other companies to follow Pfizer's lead in rolling back price hikes.
